Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trialDafin F. Mureșanu, Johannes Vester, Olivia Verișezan Roșu et al.|Neurological Sciences|2020Cited by 55
Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trialWai Sang Poon, Johannes Vester, Christian Matula et al.|Neurological Sciences|2019Cited by 42
Differences in Health-Related Quality of Life after Traumatic Brain Injury between Varying Patient Groups: Sensitivity of a Disease-Specific (QOLIBRI) and a Generic (SF-36) InstrumentNicole von Steinbüchel, Amra Čović, Mirjam Meeuwsen et al.|Journal of Neurotrauma|2019Cited by 22
Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial seriesJohannes Vester, Dafin F. Mureșanu, Anca Dana Buzoianu et al.|Neurological Sciences|2021Cited by 22
Correction to: Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trialWai Sang Poon, Johannes Vester, Christian Matula et al.|Neurological Sciences|2020Cited by 1